# Eysuvis

NDC: 71571-333
Generic name: loteprednol etabonate
Labeler / Manufacturer: ALCON LABORATORIES, INC.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SUSPENSION/ DROPS
Routes: OPHTHALMIC
Marketing started: 20201118

FDA application: NDA210933

## Active ingredients

- LOTEPREDNOL ETABONATE: 2.5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71571-333"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71571-333
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a2169d82-4275-4ab6-a1c3-c274080b815c